Intellimed Healthcare is a Singapore-based MedTech company advancing AI-driven wound care management across Southeast Asia. Our mission is to address the fragmented, high-cost nature of chronic wound care by combining clinically proven wound care products with a modular AI platform that integrates seamlessly into existing care pathways.

Our platform empowers frontline care teams with standardized wound assessments, decision-tree treatment planning, healing progression monitoring, and escalation protocols. By embedding these tools directly into clinical workflows, we improve consistency, reduce variability, and generate actionable data to support value-based reimbursement. The platform is built to scale longitudinally—starting with wound management and expanding into digital podiatry, glycemic integration, and chronic disease tracking.

To date, Intellimed supports over 30 hospitals and clinics across Singapore, Malaysia, and Brunei, with active pilot discussions underway in Indonesia and integration with leading home care providers. Our hybrid go-to-market model—product-led, platform-scaled—enables immediate adoption and long-term strategic positioning.

Intellimed is now seeking funding to support pilot collaborations and regional expansion. With a strong commercial foundation, a growing data infrastructure, and partnerships in motion, we are poised to become the leading platform for intelligent wound and chronic care management in Asia.